The NDE1 genomic locus can affect treatment of psychiatric illness through gene expression changes related to microRNA-484

Nicholas J. Bradshaw, Liisa Ukkola-Vuoti, Maiju Pankakoski, Amanda B. Zheutlin, Alfredo Ortega-Alonso, Minna Torniainen-Holm, Vishal Sinha, Sebastian Therman, Tiina Paunio, Jaana Suvisaari, Jouko Lonnqvist, Tyrone D. Cannon, Jari Haukka, William Hennah

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number170153
JournalOpen biology
Volume7
Issue number11
Number of pages11
ISSN2046-2441
DOIs
Publication statusPublished - Nov 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • schizophrenia
  • gene expression
  • DISCI network
  • NDE1
  • miR-484
  • pharmacogenetics
  • COPY NUMBER VARIANTS
  • NEURODEVELOPMENTAL DISORDERS
  • SCHIZOPHRENIA SUSCEPTIBILITY
  • CYTOCHROME-P450 2D6
  • BRAIN-DEVELOPMENT
  • RISK-FACTOR
  • DISC1
  • ASSOCIATION
  • MUTATIONS
  • HAPLOTYPE
  • 3124 Neurology and psychiatry
  • 3112 Neurosciences
  • 1182 Biochemistry, cell and molecular biology

Cite this